CD8A and neoplasm: Accordingly, when coadministered with DOX, TCP prevented the enrichment of ICD–CSCs and the increase in the percentage of TIM3+ CD8+ tumor-infiltrating lymphocytes in MCA205 tumor-bearing mice (Fig. 6f), resulting in improved tumor growth control and mice survival compared with DOX alone (Fig. 6g).